Roman Butler Fullerton & Co’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Roman Butler Fullerton & Co's ACLS Position: Q4 2023 in Review
Roman Butler Fullerton & Co sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 7,331 shares — an estimated $1.18M sold.
Roman Butler Fullerton & Co first reported a position in ACLS in Q4 2021 and held it in 4 quarters. The position peaked at $1.51M in Q2 2023. 420 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.
- Roman Butler Fullerton & Co reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
- Roman Butler Fullerton & Co sold 7,331 Axcelis shares in Q4 2023, an estimated $1.18M.
- Roman Butler Fullerton & Co first reported a position in Axcelis in Q4 2021 and held it in 4 quarters.
- Roman Butler Fullerton & Co's Axcelis position peaked at $1.51M in Q2 2023.
- 420 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.
Based on Roman Butler Fullerton & Co's 13F filing for Q4 2023, filed 31 Jan 2024.